A prospective evaluation of the use of intestinal ultrasound as an assessment tool in predicting the course of intestinal inflammation and response to therapy in patients with inflammatory bowel disease

Not Applicable

Completed

• Conditions: inflammatory bowel disease; Oral and Gastrointestinal - Inflammatory bowel disease

• Registration Number: ACTRN12621000168853
• Lead Sponsor: Monash University - Central Clinical School

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2021-01-11
• Study Start: 2021-02-18
• Last Update Posted: 22 February 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 41

Inclusion Criteria

1. 18 years or above with a diagnosis of inflammatory bowel disease
2. Commencing new medical therapy for inflammatory bowel disease
3. Inflammatory bowel disease visible on gastrointestinal ultrasound

Exclusion Criteria

1. Patients with perianal disease as the predominant problem
2. Patients with disease distribution known to be proctitis
3. Patients unable to give informed consent

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The proportion of patients achieving sonographic remission or response by week 14. <br><br>[Week 14 post initiation of treatment ]